Cargando…
Phase separation of FSP1 promotes ferroptosis
Ferroptosis is evolving as a highly promising approach to combat difficult-to-treat tumour entities including therapy-refractory and dedifferentiating cancers(1–3). Recently, ferroptosis suppressor protein-1 (FSP1), along with extramitochondrial ubiquinone or exogenous vitamin K and NAD(P)H/H(+) as...
Autores principales: | Nakamura, Toshitaka, Hipp, Clara, Santos Dias Mourão, André, Borggräfe, Jan, Aldrovandi, Maceler, Henkelmann, Bernhard, Wanninger, Jonas, Mishima, Eikan, Lytton, Elena, Emler, David, Proneth, Bettina, Sattler, Michael, Conrad, Marcus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338336/ https://www.ncbi.nlm.nih.gov/pubmed/37380771 http://dx.doi.org/10.1038/s41586-023-06255-6 |
Ejemplares similares
-
Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation
por: Nakamura, Toshitaka, et al.
Publicado: (2023) -
A non-canonical vitamin K cycle is a potent ferroptosis suppressor
por: Mishima, Eikan, et al.
Publicado: (2022) -
Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines
por: Zheng, Jiashuo, et al.
Publicado: (2021) -
Ferroptosis: the Good, the Bad and the Ugly
por: Aldrovandi, Maceler, et al.
Publicado: (2020) -
Structural insights into FSP1 catalysis and ferroptosis inhibition
por: Lv, Yun, et al.
Publicado: (2023)